Greenwich Lifesciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$23.37

-0.38 (-1.60%)

As of Jun 23, 3:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +45.7% upside

Low Target $25.54

Average Target $34.05

High Target $45.13

Current Price $23.37

Current
$23.37

Target
$34.05

$25.54 $34.05 avg $45.13

Scenario Analysis

Bear Case

$25.54

9.3%

Low target

Base Case

$34.05

+45.7%

Avg target

Bull Case

$45.13

+93.1%

High target

Risk/Reward

10.0x

Highly favorable

Price in Context

52-Week High

$34.10

-31.5% from high

52-Week Low

$7.78

+200.4% from low

Target vs 52W High

$34.05

-0.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%